Brief: Immunovia Q1 Adjusted EPS SEK -0.07
29/04/2024 07:30
Apr 29 (Reuters) - Immunovia Q1 adjusted free cash flow SEK -24.4 million. * Q1 net income SEK -2.946 million
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study